CCL5 and neoplasm: They can secrete IL-12p70, TNF-α, IL-10, RANTES, and CCL2 in response to TLR agonists, and confer protective immunity against tumor challenge in the presence of maturation agents such as CD40L or after co-culture with apoptotic/necrotic tumor cells (130, 131).